The Electrospinning Company Ltd. Revenue and Competitors

Didcot,

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • The Electrospinning Company Ltd.'s estimated annual revenue is currently $4.9M per year.(i)
  • The Electrospinning Company Ltd.'s estimated revenue per employee is $136,000

Employee Data

  • The Electrospinning Company Ltd. has 36 Employees.(i)
  • The Electrospinning Company Ltd. grew their employee count by 6% last year.

The Electrospinning Company Ltd.'s People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Finance and Facilities ManagerReveal Email/Phone
3
Project ManagerReveal Email/Phone
4
Quality ManagerReveal Email/Phone
5
Manufacturing EngineerReveal Email/Phone
6
Non Executive ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.4M114-37%N/AN/A
#2
$1.1M110%N/AN/A
#3
$5.6M41N/AN/AN/A
#4
$5780M77268%N/AN/A
#5
$9.9M655%N/AN/A
#6
$41.7M22324%N/AN/A
#7
$24270M2786321%$4BN/A
#8
$207.3M871N/AN/AN/A
#9
$4M528%N/AN/A
#10
$4.2M31N/AN/AN/A
Add Company

What Is The Electrospinning Company Ltd.?

We design, develop and manufacture advanced biomaterials for use in implantable tissue-regenerative devices. The company supplies the first electrospun material to be incorporated into an FDA-approved medical device that promotes endogenous tissue repair in orthopaedic surgery. Our tried and tested processes support our customers from developing electrospun prototypes towards registration with the FDA or notified bodies and long term manufacturing. Our experience in electrospinning, manufacturing and quality management allows us to offer cost effective production of electrospun medical devices at scale. With over 30 years of combined experience in biomedical electrospinning, we are actively looking to engage with other partners to bring the benefits of electrospun biomaterials to a range of therapeutic indications. The company operates out of Class VII clean rooms and holds ISO 13485:2016 medical device quality certification.

keywords:N/A

N/A

Total Funding

36

Number of Employees

$4.9M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Electrospinning Company Ltd. News

2022-04-06 - Global Ophthalmic Drug Delivery Systems Market (2022 to 2030) - Size, Share & Trends Analysis Report

Santen Pharmaceutical Co. Ltd. 9.3.6.1. Company overview 9.3.6.2. Financial performance 9.3.6.3. Product benchmarking 9.3.6.4.

2022-04-06 - Outlook on the Ophthalmic Drug Delivery Systems Global ...

Electrospinning 6.1.2. 3D printing 6.1.3. Extrusion ... Key company market share analysis, 2021 ... Santen Pharmaceutical Co. Ltd. 9.3.6.1.

2022-03-22 - Global Markets and Technologies for Nanofibers

It will also analyze the major challenges faced by nanofiber manufacturers and end ... Ltd., Showa Denko K.K., and Toray Industries Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M4860%N/A
#2
$7.8M60N/AN/A
#3
$13.2M607%N/A
#4
$13.8M957%N/A
#5
$25.6M16519%N/A